BridgeMD
New treatment option for Spastic Hemiplegic Cerebral Palsy
Official title Effect of Lower Extremity Modified Constraint-induced Movement Therapy on Locomotion in Children With Hemiplegia
ClinicalTrials.gov ID: NCT07686809
What this study is testing
- What it's testing
- To determine the effect of modified constraint-induced movement therapy on spatial and temporal gait parameters in children with hemiplegia. To determine the effect of modified constraint-induced movement therapy on functional mobility in children with hemiplegia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 8
You may be able to join if
- The age of the selected children will range from 6 to 8 years old.
- Degree of spasticity will range from 1+ to 2 according to the modified Ashworth scale.
- The level of motor function of the children will be levels I-II according to the Gross Motor Function Classification System.
- Participants will present a score between 41 to 56 points on the pediatric balance scale.
- They will be able to follow instructions and understand commands.
You likely can't join if
- Bone and tendon lengthening surgeries within the last 6 months.
- Lung and heart diseases and disorders.
- Vision or hearing problems.
- Children with fixed deformities in the lower extremity.
- Children with epilepsy.
- Recent intramuscular Botulinum toxin injection.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 8 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.